Clinical Utility of the HELT-E(2)S(2) Score for Risk Stratification in Patients with Acute Decompensated Heart Failure: Insights from the CURE-HF Registry

HELT-E(2)S(2)评分在急性失代偿性心力衰竭患者风险分层中的临床应用:来自CURE-HF注册研究的启示

阅读:1

Abstract

Objective The HELT-E(2)S(2) score is a novel risk assessment tool for ischemic stroke in patients with atrial fibrillation. We explored the prognostic impact of the HELT-E(2)S(2) score on cardiovascular outcomes in patients with heart failure (HF), beyond its original scope. Methods We enrolled 997 patients hospitalized for acute decompensated HF (ADHF) (median age, 81 years; 44.3% female) from the Clue of Risk Stratification in the Elderly Patients with Heart Failure (CURE-HF) registry. We evaluated the relationship between the HELT-E(2)S(2) score and all-cause death over a median follow-up of 2.7 years. Results The patients were categorized into four quartiles based on the HELT-E(2)S(2) score: score 0 or 1 (group 1, n=234), score 2 (group 2, n=244), score 3 (group 3, n=255), and score ≥4 (group 4, n=264). Atrial fibrillation was present in 592 (59.4%) patients (paroxysmal, 15.0%; persistent, 44.3%). All-cause death was observed in 384 patients (14.7 per 100 patient-years). A Kaplan-Meier analysis showed that the higher score group was associated with an increased risk of all-cause death (log-rank p<0.001). After multivariable adjustment, the higher score groups had an elevated risk of all-cause death compared to group 1 [group 2; hazard ratio (HR): 1.56; 95% confidence interval (CI): 1.03-2.37; p=0.037, group 3; HR: 2.74; 95% CI: 1.85-4.07; p<0.001, group 4; HR: 3.32; 95% CI: 2.34-4.94; p<0.001]. Conclusion Higher HELT-E(2)S(2) scores were associated with a higher risk of all-cause death in patients with ADHF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。